A comprehensive overview of metaplastic breast cancer: Features and treatments
Cancer Science · 2024-08 · 115 (8) · 2506-2514
DOI: 10.1111/cas.16208 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 12.05.2024. Verfasst von Qiaoke Yan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin City, Heilongjiang Province, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Epithelial-Mesenchymal Transition. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: General Program of National Natural Science Foundation of China, Key Program of Natural Science Foundation of Heilongjiang Province of China.
Abstract (Originalsprache)
Metaplastic breast cancer is a rare, aggressive, and chemotherapy‐resistant subtype of breast cancers, accounting for less than 1% of invasive breast cancers, characterized by adenocarcinoma with spindle cells, squamous epithelium, and/or mesenchymal tissue differentiation. The majority of metaplastic breast cancers exhibit the characteristics of triple‐negative breast cancer and have unfavorable prognoses with a lower survival rate. This subtype often displays gene alterations in the PI3K/AKT pathway, Wnt/β‐catenin pathway, and cell cycle dysregulation and demonstrates epithelial–mesenchymal transition, immune response changes, TP53 mutation, EGFR amplification, and so on. Currently, the optimal treatment of metaplastic breast cancer remains uncertain. This article provides a comprehensive review on the clinical features, molecular characteristics, invasion and metastasis patterns, and prognosis of metaplastic breast cancer, as well as recent advancements in treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin City, Heilongjiang Province, China.
- Department of Medical Oncology, Heilongjiang Cancer Prevention and Treatment Institute, Harbin City, Heilongjiang Province, China.
ORCID-Profile: Qiaoke Yan, Yuwei Deng, Qingyuan Zhang
Förderung
- General Program of National Natural Science Foundation of China
- Key Program of Natural Science Foundation of Heilongjiang Province of China
Zitieren
APA
Yan, Q., Deng, Y., & Zhang, Q. (2024). A comprehensive overview of metaplastic breast cancer: Features and treatments. Cancer Science, 115(8), 2506-2514. https://doi.org/10.1111/cas.16208
Vancouver
Yan Q, Deng Y, Zhang Q. A comprehensive overview of metaplastic breast cancer: Features and treatments. Cancer Science. 2024;115(8):2506-2514. doi:10.1111/cas.16208
BibTeX
@article{Yan2024,
author = {Yan, Qiaoke and Deng, Yuwei and Zhang, Qingyuan},
title = {A comprehensive overview of metaplastic breast cancer: Features and treatments},
journal = {Cancer Science},
year = {2024},
volume = {115},
number = {8},
pages = {2506--2514},
doi = {10.1111/cas.16208}
}
EUVIMED